Free Trial
NASDAQ:IKNA

Ikena Oncology (IKNA) Stock Price, News & Analysis

Ikena Oncology logo
$1.33 +0.02 (+1.53%)
Closing price 07/3/2025 02:00 PM Eastern
Extended Trading
$1.40 +0.06 (+4.89%)
As of 08:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Ikena Oncology Stock (NASDAQ:IKNA)

Key Stats

Today's Range
$1.31
$1.34
50-Day Range
$1.08
$1.47
52-Week Range
$0.97
$1.94
Volume
8,098 shs
Average Volume
115,294 shs
Market Capitalization
$64.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00
Consensus Rating
Moderate Buy

Company Overview

Ikena Oncology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

IKNA MarketRank™: 

Ikena Oncology scored higher than 48% of companies evaluated by MarketBeat, and ranked 553rd out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ikena Oncology has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Ikena Oncology has received no research coverage in the past 90 days.

  • Read more about Ikena Oncology's stock forecast and price target.
  • Earnings Growth

    Earnings for Ikena Oncology are expected to grow in the coming year, from ($0.91) to ($0.82) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ikena Oncology is -1.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ikena Oncology is -1.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ikena Oncology has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ikena Oncology's valuation and earnings.
  • Percentage of Shares Shorted

    0.39% of the float of Ikena Oncology has been sold short.
  • Short Interest Ratio / Days to Cover

    Ikena Oncology has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ikena Oncology has recently increased by 0.75%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Ikena Oncology does not currently pay a dividend.

  • Dividend Growth

    Ikena Oncology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.39% of the float of Ikena Oncology has been sold short.
  • Short Interest Ratio / Days to Cover

    Ikena Oncology has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ikena Oncology has recently increased by 0.75%, indicating that investor sentiment is decreasing.
  • Search Interest

    1 people have searched for IKNA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ikena Oncology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.94% of the stock of Ikena Oncology is held by insiders.

  • Percentage Held by Institutions

    75.00% of the stock of Ikena Oncology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Ikena Oncology's insider trading history.
Receive IKNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ikena Oncology and its competitors with MarketBeat's FREE daily newsletter.

IKNA Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
William Blair Reaffirms Their Buy Rating on Ikena Oncology (IKNA)
Ikena Oncology, Inmagene Biopharmaceuticals to Merge
See More Headlines

IKNA Stock Analysis - Frequently Asked Questions

Ikena Oncology's stock was trading at $1.64 at the start of the year. Since then, IKNA shares have decreased by 18.9% and is now trading at $1.33.

Ikena Oncology, Inc. (NASDAQ:IKNA) issued its quarterly earnings results on Thursday, May, 8th. The company reported ($0.18) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.03.

Ikena Oncology (IKNA) raised $125 million in an IPO on Friday, March 26th 2021. The company issued 7,800,000 shares at a price of $15.00-$17.00 per share. Jefferies, Cowen, Credit Suisse and William Blair served as the underwriters for the IPO.

Shares of IKNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ikena Oncology investors own include Waste Connections (WCN), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), DiamondRock Hospitality (DRH), American Water Works (AWK), AU Optronics (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
5/08/2025
Today
7/07/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IKNA
Fax
N/A
Employees
70
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$4.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+125.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.23 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.16 million
Price / Cash Flow
N/A
Book Value
$2.61 per share
Price / Book
0.51

Miscellaneous

Free Float
45,391,000
Market Cap
$64.19 million
Optionable
Not Optionable
Beta
0.50
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:IKNA) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners